Cargando…

Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women

PURPOSE: Obesity is associated with poorer outcomes in patients with hormone receptor-positive breast cancers, but this association is not well established for women with triple-negative breast cancers (TNBC). Here, we investigated the prognostic effects of body mass index (BMI) on clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Shuang, Liu, Yin, Yu, Ke-Da, Chen, Sheng, Yang, Wen-Tao, Shao, Zhi-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479880/ https://www.ncbi.nlm.nih.gov/pubmed/26107623 http://dx.doi.org/10.1371/journal.pone.0129741

Ejemplares similares

New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer
por: Hao, Shuang, et al.
Publicado: (2016)

The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer — A Cohort from China
por: Yin, Liu, et al.
Publicado: (2018)

Overweight: Is It a Prognostic Factor in Women with Triple-Negative Breast Cancer?
por: Jarroudi, Ouissam Al, et al.
Publicado: (2017)

Obesity or Overweight Is Associated with Worse Pathological Response to Neoadjuvant Chemotherapy among Chinese Women with Breast Cancer
por: Chen, Sheng, et al.
Publicado: (2012)

Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
por: Chen, Hong-liang, et al.
Publicado: (2016)

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
por: Zhu, Si-Yuan, et al.
Publicado: (2021)

Triple negative breast carcinoma is a prognostic factor in Taiwanese women
por: Lin, Che, et al.
Publicado: (2009)

Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women
por: Ling, Hong, et al.
Publicado: (2016)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
por: Wang, Ruo-Xi, et al.
Publicado: (2018)

Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer
por: Ren, Kuojun, et al.
Publicado: (2018)

The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer
por: He, Min, et al.
Publicado: (2017)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index
por: Huang, Liang, et al.
Publicado: (2013)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
por: Lin, Yanping, et al.
Publicado: (2009)

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2015)

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
por: Zhou, Yi-Fan, et al.
Publicado: (2021)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer
por: Yin, Hsin-Ling, et al.
Publicado: (2016)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
por: Liu, Yi-Rong, et al.
Publicado: (2016)

Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status
por: Ye, Shuang, et al.
Publicado: (2019)

MicroRNA‐493 is a prognostic factor in triple‐negative breast cancer
por: Yao, Ling, et al.
Publicado: (2018)

Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer
por: Sha, Shengnan, et al.
Publicado: (2022)

Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
por: Cao, Jintao, et al.
Publicado: (2021)

Prognostic significance of GSTP1 in patients with triple negative breast cancer
por: Chen, Guanglei, et al.
Publicado: (2017)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer
por: Shi, Bingye, et al.
Publicado: (2023)

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis
por: Chen, Yi-Yu, et al.
Publicado: (2022)

Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis
por: Chen, Chao, et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis
por: Harborg, Sixten, et al.
Publicado: (2021)

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial
por: Yu, Ke-Da, et al.
Publicado: (2020)

TLR5: A prognostic and monitoring indicator for triple-negative breast cancer
por: Shi, Dai, et al.
Publicado: (2019)

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
por: Lin, Cai-Jin, et al.
Publicado: (2023)

Oncolytic viruses for triple negative breast cancer and beyond
por: Jin, Shengye, et al.
Publicado: (2021)

Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer
por: Li, Meng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_762b2mnpehead5k00uhbkthunm